Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Natco Pharma Limited patents

Recent patent applications related to Natco Pharma Limited. Natco Pharma Limited is listed as an Agent/Assignee. Note: Natco Pharma Limited may have other listings under different names/spellings. We're not affiliated with Natco Pharma Limited, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | Natco Pharma Limited-related inventors




Date Natco Pharma Limited patents (updated weekly) - BOOKMARK this page
04/27/171h-1,8-naphthyridin-2ones as anti proliferative compounds
03/23/176,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors
12/10/15Anhydrous lenalidomide form-i
07/02/15Process for the preparation of nilotinib
05/21/156,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors
04/30/15Process for the preparation of 2-substituted-2-(6-(substituted)-7-methylbenzo[d][1,3]dioxol-4-yl)acetic acid derivatives
03/19/15Fermentation process for the production of rapamycin
05/01/14Anhydrous lenalidomide form-i
12/19/13Formulation comprising phenylaminopyrimidine derivative as active agent
09/19/13Process for the preparation of bosentan monohydrate
08/15/13Process for the preparation of nilotinib
07/18/13Process to prepare s-2-hydroxy-3-methoxy-3,3-diphenyl propionic acid
07/04/13Process to prepare ethyl 4-methyl-2-(4-(2-methylpropyloxy)-3-cyanophenyl)-5-thiazolecarboxylate
05/23/13Novel polymorphs of erlotinib hydrochloride and preparation
03/07/13Anhydrous lenalidomide form-i
03/07/13Process for the preparation of highly pure crystalline imatinib base
03/07/13Process for the preparation of highly pure ambrisentan
02/07/13Process for the preparation of lacosamide
12/27/12Imatinib mesylate oral pharmaceutical composition and process for preparation thereof
09/27/12Process for the preparation of lapatinib and its pharmaceutically acceptable salts
07/05/12Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agent
03/29/12Acid addition salts of (3,5-bis trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide
03/08/12Process for the preparation of lanthanum carbonate dihydrate
10/27/11Novel process for the preparation of lapatinib and its pharmaceutically acceptable salts
08/04/11Acid addition salts of (3,5-bis trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide
04/21/11Process for the preparation of high purity sunitinib and its pharmaceutically acceptable salt
02/17/116-7,dialkoxy quinazoline derivatives useful for treatment of cancer related disorders
12/23/10Process for the preparation glatiramer acetate (copolymer-1)
11/25/10Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti-cancer agents
10/14/10Novel polymorphs of erlotinib hydrochloride and preparation
10/14/10Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agent
12/10/09Novel process for the prepartion of erlotinib
09/10/09Crystal form of phenylamino pyrimidine derivatives







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Natco Pharma Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Natco Pharma Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';